Cord Blood Banking in Vietnam: Historical Perspective, Status, and Future Developments 2023

被引:0
作者
Thanh-Ha, Luong Thi [1 ]
Nhat-Tung, Phan [2 ]
Thi-Thao, Chu [1 ]
Van-Phuc, Tran [1 ]
The-Dung, Nguyen [1 ]
Cong-Luc, Le [1 ]
Kien-Thach, Nguyen [1 ]
My-Trinh, Nguyen Thi [1 ]
Van-Tinh, Nguyen [1 ]
机构
[1] Vinmec HealthCare Syst, 458 Minh Khai, Hanoi 100000, Vietnam
[2] Vietnam Natl Univ, Hanoi, Vietnam
关键词
umbilical cord blood; Vietnamese umbilical cord blood banking; collection; processing; storage; MESENCHYMAL STEM/PROGENITOR CELLS; HEMATOPOIETIC STEM-CELLS; UMBILICAL-CORD; TRANSPLANTATION; QUALITY; CRYOPRESERVATION; PROGRAM; MARROW;
D O I
10.1089/bio.2023.0139
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This review summarizes biobanks of umbilical cord blood (UCB), beginning with a series of crucial experiments to build the technology to treat hematological diseases. UCB is used as an alternative source of hematopoietic stem cells in the treatment of patients with hematological malignancies, bone marrow failure, and inherited metabolic abnormalities. In this review, we evaluate the procedures for collecting, processing, and storing cord blood and discuss the advantages and disadvantages of current applications in regenerative medicine, particularly for hematological disorders in Vietnam. Our analysis compares cord blood banks, including private and public banks, in Vietnam and worldwide. An integrative overview of UCB transplantation in patients with different diseases and the degree of patient adaptation is analyzed. This review concludes with an assessment of the impact of measures taken to combat the COVID-19 pandemic on the banking of autologous cord blood and cord tissue in Vietnam compared to other banks in the world. National policies in the fight against a pandemic may differ from the global level. Human behavior, access to medical treatment, number of health professionals, health facility infrastructure, and timing of response in different cultures contribute to these differences.
引用
收藏
页数:10
相关论文
共 65 条
  • [11] Allogeneic cord blood red blood cells: assessingcord blood unitfractionation and validation
    Bianchi, Maria
    Orlando, Nicoletta
    Barbagallo, Ombretta
    Sparnacci, Sabrina
    Valentini, Caterina Giovanna
    Carducci, Brigida
    Teofili, Luciana
    [J]. BLOOD TRANSFUSION, 2021, 19 (05) : 435 - 444
  • [12] Binh TN., 2021, Store umbilical cord blood', Stem cell central
  • [13] BobikKurz KFM., 2020, Stem Cells Transl Med, V9, P18
  • [14] The effect of COVID-19 public health measures on nationally notifiable diseases in Australia: preliminary analysis
    Bright, Amy
    Glynn-Robinson, Anna-Jane
    Kane, Stacey
    Wright, Rose
    Saul, Nathan
    [J]. COMMUNICABLE DISEASES INTELLIGENCE, 2020, 44
  • [15] Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease
    Brunstein, Claudio G.
    Barker, Juliet N.
    Weisdorf, Daniel J.
    DeFor, Todd E.
    Miller, Jeffrey S.
    Blazar, Bruce R.
    McGlave, Philip B.
    Wagner, John E.
    [J]. BLOOD, 2007, 110 (08) : 3064 - 3070
  • [16] Center HCMCBTaH, 2002, Confirming the first successful cord blood transplant
  • [17] Christopher H., 2005, H.R.2520-109th Congress (2005-2006). U.S, P109
  • [18] Corrales C., 2023, ARPHA Prepr, V4, pe103105, DOI [10.3897/arphapreprints.e103105, DOI 10.3897/ARPHAPREPRINTS.E103105]
  • [19] cryo-cell, Who can use the umbilical cord blood?
  • [20] dantri, Where is Vietnam standing in the world stem cell transplant map?